Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-02-20 @ 6:38 PM
Study NCT ID:
NCT02035956
Status:
COMPLETED
Last Update Posted:
2020-01-18
First Post:
2014-01-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
IVAC MUTANOME Phase I Clinical Trial
Sponsor:
BioNTech RNA Pharmaceuticals GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RB_0004-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None